Krystal Biotech to Present at BofA Securities 2026 Health Care Conference

Krystal Biotech (NASDAQ: KRYS) will participate in the BofA Securities 2026 Health Care Conference on May 13, 2026 in Las Vegas.

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) will participate in the BofA Securities 2026 Health Care Conference on May 13, 2026 in Las Vegas. Krish S. Krishnan, chairman and CEO, will join a fireside chat at 11:20 am PT and hold investor meetings the same day. A webcast will be available beginning at 11:20 am PT on the company’s Investors website.

Argus May 7 session

+2.67% close to close Open Argus

Details

News Market Reaction – KRYS

On May 7, the day this news came out, KRYS closed 2.67% above the previous close.

Data tracked by StockTitan Argus for the May 7 session.

Market Context

This announcement highlights Krystal Biotech’s participation in the BofA Securities 2026 Health Care...

Analysis

This announcement highlights Krystal Biotech’s participation in the BofA Securities 2026 Health Care Conference on May 13, 2026, including a fireside chat at 11:20 am PT and investor meetings. It follows recent strong quarterly results and multiple regulatory filings. Investors may focus on whether management adds incremental detail on commercial traction, pipeline timelines, or capital allocation beyond what was disclosed in recent earnings and SEC reports.

Key Figures

Conference date: May 13, 2026 Fireside chat time: 11:20 am PT

Conference date

May 13, 2026

BofA Securities 2026 Health Care Conference participation

Fireside chat time

11:20 am PT

Scheduled presentation start time at conference

Historical Context

5 past events · Latest: May 04

5 events

1. May 04

   Earnings results

   24h Move

   +7.9%

   Strong 1Q 2026 revenue and cash position with updated guidance.

2. Apr 30

   Conference presentations

   24h Move

   +0.9%

   Plans to present multiple gene therapy programs at scientific meetings.

3. Apr 21

   Earnings date notice

   24h Move

   -1.4%

   Announcement of timing for 1Q 2026 results and conference call.

4. Feb 24

   Investor conference

   24h Move

   -2.8%

   Participation in TD Cowen health care conference with fireside chat.

5. Feb 17

   Earnings results

   24h Move

   +4.1%

   Strong 4Q and FY2025 results and multiple regulatory milestones.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, May 07, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2026 Health Care Conference on May 13, 2026, in Las Vegas. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 11:20 am PT and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 11:20 am PT on Wednesday, May 13, 2026 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. Visit www.krystalbio.com to learn more or follow us on LinkedIn and X.

CONTACT
Investors and Media:                                                             
Stéphane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com                                    

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Krystal Biotech (KRYS) present at the BofA Securities 2026 Health Care Conference?

Krystal Biotech will present on May 13, 2026 at the BofA Health Care Conference. According to Krystal Biotech, the company’s fireside chat is scheduled for 11:20 am PT, with additional investor meetings occurring throughout that day in Las Vegas.

Who from Krystal Biotech (KRYS) will speak at the May 13, 2026 presentation?

Krish S. Krishnan, chairman and CEO, will take part in the fireside chat. According to Krystal Biotech, Krishnan will also host investor meetings throughout the day, providing opportunities for one-on-one and group discussions with investors attending the conference.

How can investors watch Krystal Biotech's (KRYS) webcast from the BofA 2026 conference?

A webcast will be available starting at 11:20 am PT on May 13, 2026. According to Krystal Biotech, the webcast will be accessible via the Investors section of the company website and will be posted there beginning at the scheduled start time.

What time is Krystal Biotech's (KRYS) fireside chat at the BofA 2026 Health Care Conference?

The fireside chat is scheduled for 11:20 am PT on May 13, 2026. According to Krystal Biotech, the company will begin the webcast at that time and Krish S. Krishnan will lead the session at the stated start time.

Will Krystal Biotech (KRYS) hold investor meetings at the BofA Securities 2026 Health Care Conference?

Yes, Krystal Biotech will host investor meetings throughout May 13, 2026. According to Krystal Biotech, these meetings will occur the same day as the fireside chat in Las Vegas and are intended to provide additional investor engagement opportunities.

Where will the Krystal Biotech (KRYS) conference webcast be posted after the presentation?

The webcast will be posted on the company’s Investors website after it begins. According to Krystal Biotech, the presentation webcast will be available beginning at 11:20 am PT on May 13, 2026 and then posted on the Investors section for later viewing.